China Pharma (NYSE:CPHI) Now Covered by StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the stock.

China Pharma Stock Up 7.3 %

China Pharma stock opened at $0.27 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.24 and a debt-to-equity ratio of 0.19. China Pharma has a 52-week low of $0.17 and a 52-week high of $1.21. The company’s 50 day moving average is $0.21 and its two-hundred day moving average is $0.27.

China Pharma (NYSE:CPHI) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The company had revenue of $0.93 million for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.